Lilly Declares Third-Quarter 2024 Dividend

Group 1 - Eli Lilly and Company has declared a dividend of $1.30 per share for the third quarter of 2024, payable on September 10, 2024, to shareholders of record as of August 15, 2024 [1] - The company has been a pioneer in medical discoveries for nearly 150 years, helping over 51 million people globally [2] - Eli Lilly focuses on addressing significant health challenges, including diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers [2] Group 2 - The company emphasizes the importance of innovative clinical trials that reflect global diversity and aims to ensure the accessibility and affordability of its medicines [2]